Alchemab raised $32m in Series A extension funding from OVI, RA Capital, SV Health Investors, DCVC Bio , Lightstone Ventures, and Eli Lilly.
03 September 2025
03 September 2025
Total investments received (USD): 115.01M
Round value (USD): 32M
Company: Alchemab
Industry: BiotechHealth services
Related deals
Relation Tx raised $26m from insiders NVentures, DCVC, and Magnetic Ventures.
Investments
02 December 2025
EpilepsyGTx raised $33m in Series A funding from XGEN Venture and the British Business Bank.
Investments
02 December 2025
T-Therapeutics in a $32 million series A extension with Tencent, BGF, Sofinnova, F-Prime, Digitalis Ventures, Cambridge Innovation, Sanofi.
Investments
03 November 2025
Cyted Health raises €37.5 million in a Series B financing round led by EQT Life Sciences, Advent Life and British Business Bank, w/ Morningside and BGF.
Investments
01 August 2025
Portal Biotech raised $35m Series A round co-led by NATO and Earlybird, joined by SCVC, Pillar VC, 8VC, Amino Collective, Outsized, We Venture Capital.
Investments
20 June 2025
Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Portugal